Agreement provides ProQR with initial payment of ‚¬12.5M and up to ‚¬135M in further payments, as well as potential additional earn outs based on commercial sales in the US and EU Divestment of...
Wracked with quality question marks that have caused major shortages of common cancer drugs, India-based generic drug manufacturer Intas Pharmaceuticals has been handed a warning letter from the FDA over several data issues, including shredded and destroyed documents.
CLERMONT-FERRAND, France--(BUSINESS WIRE)--Laboratoires Théa SAS (“Théa”), Europe’s leading independent pharmaceutical company specializing in the research, development, and commercialization of eye-care products, today announced an agreement to purchase seven branded ophthalmic products from Akorn Operating Company LLC. The transaction will make Théa a best-in-class provider of products designed to fill the needs of eye-care professionals across the United States.